US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Polyrizon Ltd.

0.9696

-0.0804-7.66%

Post-market: 0.9600-0.0096-0.99%19:59 EDT

Volume:1.04M

Turnover:1.04M

Market Cap:5.17M

PE:- -

High:1.07

Open:1.07

Low:0.9661

Close:1.05

Loading ...

Overview Company News Filings

S&P 500 Gains 1%; April Jobs Top Expectations

Polyrizon - Will Effect a Reverse Share Split of Co’s Ordinary Shares at Ratio of 1-for-10

THOMSON REUTERS

Polyrizon reports safety study results for PL-14 Allergy Blocker formulation

Polyrizon Reports Successful Safety Study of a Formulation of Pl-14 Allergy Blocker in Human Nasal Tissue Model

THOMSON REUTERS

Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting

Polyrizon Gets Nasdaq Noncompliance Notice Over Minimum Bid Price Rule

MT Newswires Live

BRIEF-Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

THOMSON REUTERS

BRIEF-Polyrizon Enters Agreement With Global Branding Consultancy Firm

Polyrizon Ltd - Enters Agreement With Global Branding Consultancy Firm

THOMSON REUTERS

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Ltd. Secures $17 Million in Private Placement to Advance Hydrogel Technology

BRIEF-Polyrizon Ltd. Announces Closing Of $17.0 Million Private Placement

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

THOMSON REUTERS

Polyrizon Ltd. Announces $17.0 Million Private Placement

THOMSON REUTERS

Polyrizon Ltd. Announces $17.0 Million Private Placement

BRIEF-Polyrizon Structures Clinical Strategy For Its Allergy Blocker Ahead Of FDA Pre-Submission Meeting

Polyrizon Ltd - Expects to Initiate Clinical Trials in U.S. and Europe in Late 2025

THOMSON REUTERS

Polyrizon Structures Clinical Strategy for Its Allergy Blocker Ahead of FDA Pre-Submission Meeting

THOMSON REUTERS

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLRZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":0.9696,"timestamp":1752782400000,"preClose":1.05,"halted":0,"volume":1044579,"hourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9696,"latestTime":"19:59 EDT","volume":80139,"amount":77463.1088,"timestamp":1752796798310},"delay":0,"floatShares":5328000,"shares":5328000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.0804,"latestTime":"07-17 16:00:00 EDT","open":1.07,"high":1.07,"low":0.9661,"amount":1043838.1845732001,"amplitude":0.098952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752825600000},"marketStatusCode":0,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":1.05,"preHourTrading":{"tag":"盘前","latestPrice":1.03,"preClose":1.05,"latestTime":"09:29 EDT","volume":115594,"amount":118403.2925414,"timestamp":1752758999999},"postHourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9696,"latestTime":"19:59 EDT","volume":80139,"amount":77463.1088,"timestamp":1752796798310},"volumeRatio":0.041444},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":5328000,"roa":"-26.65%","roe":"-57.83%","lyrEps":0,"volumeRatio":0.041444,"shares":5328000,"dividePrice":0,"high":1.07,"amplitude":0.098952,"preClose":1.05,"low":0.9661,"week52Low":0.55,"pbRate":"0.98","week52High":1200,"institutionHeld":0,"latestPrice":0.9696,"eps":0,"divideRate":0,"volume":1044579,"delay":0,"ttmEps":0,"open":1.07,"prevYearClose":542.5,"prevWeekClose":0.707,"prevMonthClose":0.7389,"prevQuarterClose":0.7389,"fiveDayClose":0.716,"twentyDayClose":0.799,"sixtyDayClose":82.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532984722","title":"S&P 500 Gains 1%; April Jobs Top Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2532984722","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532984722?lang=en_us&edition=fundamental","pubTime":"2025-05-02 22:20","pubTimestamp":1746195652,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/05/45168390/s-april-jobs-top-expectations","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4539","SPY","BK4229","BK4007","BK4187","TQQQ","USAW.SI","VOO","BK4131",".SPX","EJH","QLD","NVIW.SI","PLRZ","FRGT","TSYW.SI","USJW.SI",".IXIC","NQmain","QID","SQQQ","MNQmain","BK4583","DPRO","IBO","PAPL","BK4603","BK4164","PSQ"],"gpt_icon":1},{"id":"2532073789","title":"Polyrizon -  Will Effect a Reverse Share Split of Co’s Ordinary Shares at Ratio of 1-for-10","url":"https://stock-news.laohu8.com/highlight/detail?id=2532073789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532073789?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:19","pubTimestamp":1746098385,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R83B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2530180184","title":"Polyrizon reports safety study results for PL-14 Allergy Blocker formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2530180184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530180184?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:54","pubTimestamp":1745582040,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced the preliminary safety study for a formulation of its PL-14 Allergy Blocker. Conducted on fully differentiated human nas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-reports-safety-study-results-for-pl-14-allergy-blocker-formulation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-reports-safety-study-results-for-pl-14-allergy-blocker-formulation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PL","BK4123","PLRZ"],"gpt_icon":0},{"id":"2530518908","title":"Polyrizon Reports Successful Safety Study of a Formulation of Pl-14 Allergy Blocker in Human Nasal Tissue Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2530518908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530518908?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:37","pubTimestamp":1745581020,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nTUA7RWJLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2528776425","title":"Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2528776425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528776425?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:51","pubTimestamp":1744923083,"startTime":"0","endTime":"0","summary":"An update from Polyrizon Ltd. ( ($PLRZ) ) is now available. On April 17, 2025, Polyrizon Ltd. held its annual general meeting where shareholders ap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-shareholders-approve-key-amendments-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-shareholders-approve-key-amendments-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2526495746","title":"Polyrizon Gets Nasdaq Noncompliance Notice Over Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2526495746","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526495746?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:40","pubTimestamp":1744404011,"startTime":"0","endTime":"0","summary":"Polyrizon  said Friday it received a notice from Nasdaq for noncompliance with the minimum closing share price requirement of $1.00 over 30 consecutive business days.The company has until Oct. 6 to regain compliance with the listing standards.It must maintain a minimum closing bid price of at least $1.00 per share for 10 consecutive trading days to meet the requirement, Polyrizon added.Shares of Polyrizon were down 5% in after-hours trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NDAQ","BK4588","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112",".IXIC","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","PLRZ","IE00B64PRP62.GBP","BK4585","NQmain"],"gpt_icon":0},{"id":"2526646517","title":"BRIEF-Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646517","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646517?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:25","pubTimestamp":1744403126,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Receives Nasdaq Notification Regarding Minimum Bid RequirementsPolyrizon Ltd PLRZ.O:POLYRIZON RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID REQUIREMENTSSource text: ID:nGNX1PjwXCFurther company coverage: PLRZ.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nTUA6T0K3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2526645942","title":"Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2526645942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526645942?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:15","pubTimestamp":1744402501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nTUA6T0K3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2524957864","title":"BRIEF-Polyrizon Enters Agreement With Global Branding Consultancy Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2524957864","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524957864?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:06","pubTimestamp":1743599193,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Enters Agreement With Global Branding Consultancy FirmApril 2 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD - ENTERS AGREEMENT WITH GLOBAL BRANDING CONSULTANCY FIRMSource text: ID:nGNX8JQ8fXFurther company coverage: PLRZ.O (((( Reuters.briefs@thomsonreuters.com ;));))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0F8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2524495293","title":"Polyrizon Ltd - Enters Agreement With Global Branding Consultancy Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2524495293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524495293?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:05","pubTimestamp":1743599149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0F8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2524549499","title":"Polyrizon Engages Leading Branding Firm for Strategic Brand Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2524549499","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524549499?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:05","pubTimestamp":1743599100,"startTime":"0","endTime":"0","summary":"Raanana, Israel, April 02, 2025  --  Polyrizon Ltd. , a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark consultancy firm, renowned for working with leading pharmaceutical and medical device companies worldwide.Under this collaboration, the firm will develop a strategic brand name and identity for Polyrizon’s proprietary Capture and Contain (C&C) hydrogel technology, an innovative intranasal spray formulation designed to create a protective biological barrier against allergens and viruses. This initiative marks a crucial step forward in Polyrizon's pathway to commercialize its technology and effectively communicate its unique benefits to the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/polyrizon-engages-leading-branding-firm-130500024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PLRZ"],"gpt_icon":0},{"id":"2524124594","title":"Polyrizon Ltd. Secures $17 Million in Private Placement to Advance Hydrogel Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2524124594","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524124594?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:02","pubTimestamp":1743541327,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. ( ($PLRZ) ) has shared an update. On March 31, 2025, Polyrizon Ltd. announced a $17.0 million private placement agreement with insti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-secures-17-million-in-private-placement-to-advance-hydrogel-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-secures-17-million-in-private-placement-to-advance-hydrogel-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2524129394","title":"BRIEF-Polyrizon Ltd. Announces Closing Of $17.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2524129394","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524129394?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:09","pubTimestamp":1743538178,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Ltd. Announces Closing Of $17.0 Million Private PlacementApril 1 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD. ANNOUNCES CLOSING OF $17.0 MILLION PRIVATE PLACEMENTSource text: ID:nGNX7lPL9ZFurther company coverage: PLRZ.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA9RX3QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2524129351","title":"Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2524129351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524129351?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:09","pubTimestamp":1743538145,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA9RX3QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2523942277","title":"Polyrizon Ltd. Announces $17.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2523942277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523942277?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:32","pubTimestamp":1743427930,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUABYKTRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2523420809","title":"Polyrizon Ltd. Announces $17.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2523420809","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523420809?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:32","pubTimestamp":1743427920,"startTime":"0","endTime":"0","summary":"RAANANA, ISRAEL, March  31, 2025  (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced that it has ente","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052399/0/en/Polyrizon-Ltd-Announces-17-0-Million-Private-Placement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2522370846","title":"BRIEF-Polyrizon Structures Clinical Strategy For Its Allergy Blocker Ahead Of FDA Pre-Submission Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522370846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522370846?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:26","pubTimestamp":1743078388,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Structures Clinical Strategy For Its Allergy Blocker Ahead Of FDA Pre-Submission MeetingMarch 27 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON STRUCTURES CLINICAL STRATEGY FOR ITS ALLERGY","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA7BSGDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2522882370","title":"Polyrizon Ltd - Expects to Initiate Clinical Trials in U.S. and Europe in Late 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522882370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522882370?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:25","pubTimestamp":1743078300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA7BSGDT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2522737088","title":"Polyrizon Structures Clinical Strategy for Its Allergy Blocker Ahead of FDA Pre-Submission Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522737088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522737088?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:25","pubTimestamp":1743078300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA7BSGDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2522930813","title":"Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522930813","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522930813?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:25","pubTimestamp":1743078300,"startTime":"0","endTime":"0","summary":"Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward. Raanana, Israel, March 27, 2025  -- Polyrizon Ltd. , a biotech company specializing in innovative intranasal hydrogels, today announced the structuring of its clinical strategy for PL-14, the Company’s proprietary intranasal allergy blocker for seasonal allergic rhinitis.The clinical strategy was updated in preparation for a planned pre-submission meeting with the U.S. Food and Drug Administration , which is expected to be followed by the initiation of clinical trials.The comprehensive clinical studies is expected to include:. A clinical study evaluating efficacy and safety under natural exposure conditions during peak allergy season. This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/polyrizon-structures-clinical-strategy-allergy-122500322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HF","BK4588","BK4023","BK4596","BK4600","BK4585","PLRZ","BK4595","BK4516","STRK"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2025-07-16","current":-3.586709,"percent":0.337143,"low":-29.515607,"twenty":-4.738839,"median":-3.032685,"eighty":-0.939338,"high":-0.011381,"avg":-3.113832,"sd":3.031332,"marketCap":5541465},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-16","current":-3.586709,"twenty":-4.738839,"median":-3.032685,"eighty":-0.939338,"marketCap":5541465}],"updateTime":1752771565871}}}